Clinical Trial Update: Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating Sitagliptin for preserving beta cell function in adults with adult-onset latent autoimmune diabetes (LADA); the trial has completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: European Foundation for the Study of Diabetes | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: COMPLETED